MYC upregulation confers resistance to everolimus and establishes vulnerability to cyclin-dependent kinase inhibitors in pancreatic neuroendocrine neoplasm cells

F Terracciano, A Capone, A Montori, M Rinzivillo… - …, 2021 - karger.com
Introduction: Dysregulation of the mechanistic target of rapamycin complex 1 (mTORC1)-
dependent pathways in pancreatic neuroendocrine neoplasms (PanNENs) underlies the …
被引用次数：10 相关文章

MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm …

F Terracciano, A Capone, A Montori… - …, 2021 - iris.uniroma1.it
Introduction: Dysregulation of the mechanistic target of rapamycin complex 1 (mTORC1)-
dependent pathways in pancreatic neuroendocrine neoplasms (PanNENs) underlies the …

MYC up-regulation confers resistance to everolimus and establishes vulnerability to cyclin dependent kinase inhibitors in pancreatic neuroendocrine neoplasms cells

F Terracciano, A Capone, A Montori… - …, 2020 - iris.unisr.it
Introduction Dysregulation of the mTORC1-dependent pathways in pancreatic
neuroendocrine neoplasms (PanNENs) underlies the introduction of the mTORC1 inhibitor …

MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm …

F Terracciano, A Capone, A Montori, M Rinzivillo… - …, 2021 - karger.com
Introduction: Dysregulation of the mechanistic target of rapamycin complex 1 (mTORC1)-
dependent pathways in pancreatic neuroendocrine neoplasms (PanNENs) underlies the …

MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm …

F Terracciano, A Capone, A Montori… - …, 2021 - search.ebscohost.com
Introduction: Dysregulation of the mechanistic target of rapamycin complex 1 (mTORC1)-
dependent pathways in pancreatic neuroendocrine neoplasms (PanNENs) underlies the …

MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm …

F Terracciano, A Capone, A Montori… - …, 2020 - europepmc.org
Methods BON-1 and everolimus-resistant (ER) BON-1 cells were used as in vitro system of
sensitivity and acquired resistance. Transcriptome changes occurring in BON-1 and ER …

MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm …

F Terracciano, A Capone, A Montori… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Dysregulation of the mechanistic target of rapamycin complex 1 (mTORC1)-
dependent pathways in pancreatic neuroendocrine neoplasms (PanNENs) underlies the …

MYC up-regulation confers resistance to everolimus and establishes vulnerability to cyclin dependent kinase inhibitors in pancreatic neuroendocrine neoplasms cells

F Terracciano, A Capone, A Montori… - …, 2020 - publicatt.unicatt.it
Introduction Dysregulation of the mTORC1-dependent pathways in pancreatic
neuroendocrine neoplasms (PanNENs) underlies the introduction of the mTORC1 inhibitor …